Tamoxifen is a widely-used conventional treatment for Breast Cancer. According to 2017 statistics, it is the 25th most “commonly prescribed” pharmaceutical in the US. Tamoxifen is a “selective estrogen receptor modulator” (SERM). But what exactly does this mean? Most importantly, what are some of the risks associated with SERMs as